Optimal management of patients with chronic hepatitis C and comorbidities.
Liver Int
; 35 Suppl 1: 35-43, 2015 Jan.
Article
em En
| MEDLINE
| ID: mdl-25529086
ABSTRACT
Although HCV infection mainly induces liver injury, chronic disease is systemic. Moreover, host and viral factors, as well as comorbidities, may influence the chance of achieving a sustained virological response or disease outcome. Although there are sufficient data on the use of peg-interferon and ribavirin in patients with comorbidities, there is very little data on first generation protease inhibitors, which include significant drug-drug interactions and have therefore been administered with caution in these patients. The availability of new, more effective direct acting antivirals should significantly change this scenario. All these issues are discussed in this review.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Inibidores de Proteases
/
Infecções por HIV
/
Hepatite C Crônica
/
Diabetes Mellitus
/
Quimioterapia Combinada
/
Hepatite B
/
Transtornos Linfoproliferativos
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
/
Systematic_reviews
Limite:
Humans
Idioma:
En
Revista:
Liver Int
Assunto da revista:
GASTROENTEROLOGIA
Ano de publicação:
2015
Tipo de documento:
Article
País de afiliação:
Itália